Debon R, Allaouchiche B, Duflo F, Boselli E, Chassard D
Department of Anesthesiology and Intensive Care, Hôtel-Dieu Hospital, Lyon-France.
Anesth Analg. 2001 Jan;92(1):180-3. doi: 10.1097/00000539-200101000-00034.
The combination of opioids with local anesthetics is commonly used for epidural labor analgesia. We examined whether increasing sufentanil in doses of 5, 10, and 15 microg prolonged the duration of labor analgesia produced by ropivacaine. One hundred healthy parturients in the first stage of labor who requested epidural analgesia were enrolled. Parturients were randomized to receive 12 mL ropivacaine 0.2% alone or with sufentanil 5 microg, sufentanil 10 microg, or sufentanil 15 microg. The duration of analgesia, pain score, degree of motor blockade (using a four-point Bromage scale), heart rate, blood pressure, respiratory rate, oxygen saturation, and incidence of nausea and pruritus were recorded. The mean duration of epidural analgesia was 96 +/- 32 min for patients without sufentanil, 134 +/- 27 min for Group 5 (p < 0.01 versus control), 135 +/- 33 min for Group 10 (p < 0.01 versus control), 130 +/- 33 min for Group 15 (p < 0.01 versus control) without differences among sufentanil groups. Between 30 and 90 min, the sufentanil groups (5 microg, 10 microg, and 15 microg) had lower pain scores than the control group (p < 0.01 versus control) but there were no differences among the sufentanil groups. No patient in any group had a Bromage score more than 1. No significant difference was found for opioid-related side effects. We conclude that 5-10 or 15 microg sufentanil induced a similar prolongation of analgesia when combined with ropivacaine 0.2% for initiation of labor analgesia.
We studied the effect of adding one of three possible sufentanil doses to epidural ropivacaine 0.2% for labor analgesia. Adding sufentanil increased the duration of analgesia but there was no advantage in adding more than 5 microg of sufentanil.
阿片类药物与局部麻醉药联合常用于硬膜外分娩镇痛。我们研究了分别增加5微克、10微克和15微克舒芬太尼是否会延长罗哌卡因产生的分娩镇痛持续时间。招募了100名处于分娩第一产程且要求硬膜外镇痛的健康产妇。产妇被随机分为单独接受12毫升0.2%罗哌卡因组或接受罗哌卡因联合5微克舒芬太尼、10微克舒芬太尼或15微克舒芬太尼组。记录镇痛持续时间、疼痛评分、运动阻滞程度(采用四点Bromage量表)、心率、血压、呼吸频率、血氧饱和度以及恶心和瘙痒的发生率。未使用舒芬太尼的患者硬膜外镇痛平均持续时间为96±32分钟,5微克组为134±27分钟(与对照组相比,p<0.01),10微克组为135±33分钟(与对照组相比,p<0.01),15微克组为130±33分钟(与对照组相比,p<0.01),舒芬太尼各剂量组之间无差异。在30至90分钟之间,舒芬太尼各剂量组(5微克、10微克和15微克)的疼痛评分低于对照组(与对照组相比,p<0.01),但舒芬太尼各剂量组之间无差异。任何组均无患者Bromage评分超过1分。在阿片类药物相关副作用方面未发现显著差异。我们得出结论,在使用0.2%罗哌卡因启动分娩镇痛时,5至10微克或15微克舒芬太尼联合使用时诱导的镇痛延长效果相似。
我们研究了在0.2%硬膜外罗哌卡因中添加三种可能剂量的舒芬太尼之一用于分娩镇痛的效果。添加舒芬太尼可延长镇痛持续时间,但添加超过5微克舒芬太尼并无优势。